AlphaYouJH
Congress trade
Sen. John Hoeven (R-ND) sold $50K-$100K of Amgen Inc. (AMGN) stock
John Hoeven, U.S. Senator (R-ND), disclosed a sale of Amgen Inc. (AMGN) stock worth $50K-$100K in a STOCK Act filing on Jan 25, 2017.
The trade happened on Jan 20, 2017, 5 days before it was made public.
AMGN has moved +160.6% since the trade date, from $154.67 to $403.04 (Oct 2, 2026 close).
- Traded
- Jan 20, 2017
- Disclosed
- Jan 25, 2017
- Filing delay
- 5 days
- Price since
- +160.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (14)
- SellABBV$100K-$250KJan 25, 2017
- BuyCSCO$100K-$250KJan 25, 2017
- SellJNJ$100K-$250KJan 25, 2017
- BuyKO$100K-$250KJan 25, 2017
- BuyPEP$100K-$250KJan 25, 2017
- BuyPG$100K-$250KJan 25, 2017
- SellBMY$50K-$100KJan 25, 2017
- BuyINTC$50K-$100KJan 25, 2017
- SellMRK$50K-$100KJan 25, 2017
- SellPFE$50K-$100KJan 25, 2017
- BuyT$50K-$100KJan 25, 2017
- BuyVFC$50K-$100KJan 25, 2017
- BuyVZ$50K-$100KJan 25, 2017
- BuyWTW$50K-$100KJan 25, 2017
More AMGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.